Back
Atea Pharmaceuticals, Inc. Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
46
AVIR
Atea Pharmaceuticals, Inc.
Last Price:
$3.66
Seasonality Move:
-23.12%
7 Day Trial
ALL ACCESS PASS
$
7
-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and AVIR is experiencing buying pressure, which is a positive indicator for future bullish movement.
Atea Pharmaceuticals, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 3.28 | Buy |
| 20-day SMA: | 3.18 | Buy |
| 50-day SMA: | 3.18 | Buy |
| 200-day SMA: | 3.18 | Buy |
| 8-day EMA: | 3.35 | Buy |
| 20-day EMA: | 3.23 | Buy |
| 50-day EMA: | 3.19 | Buy |
| 200-day EMA: | 3.22 | Buy |
Atea Pharmaceuticals, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.08 | Buy |
| Relative Strength Index (14 RSI): | 73.88 | Buy |
| Chaikin Money Flow: | 288675 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (2.99 - 3.31) | Buy |
| Bollinger Bands (100): | (3 - 3.42) | Buy |
Atea Pharmaceuticals, Inc. Technical Analysis
| Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 24 | Dec 26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | 24 | 26 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Atea Pharmaceuticals, Inc. Stock
Is Atea Pharmaceuticals, Inc. Stock a Buy?
-
Atea Pharmaceuticals, Inc. share price is 3.65 while AVIR 8-day simple moving average is 3.28, which is a Buy signal.
-
The stock price of AVIR is 3.65 while Atea Pharmaceuticals, Inc. 20-day SMA is 3.18, which makes it a Buy.
-
Atea Pharmaceuticals, Inc. 50-day simple moving average is 3.18 while AVIR share price is 3.65, making it a Buy technically.
-
AVIR stock price is 3.65 and Atea Pharmaceuticals, Inc. 200-day simple moving average is 3.18, creating a Buy signal.
AVIR Technical Analysis vs Fundamental Analysis
Sell
46
Atea Pharmaceuticals, Inc. (AVIR)
is a Sell
Is Atea Pharmaceuticals, Inc. a Buy or a Sell?
-
Atea Pharmaceuticals, Inc. stock is rated a SellThe current Atea Pharmaceuticals, Inc. [AVIR] share price is $3.65. The Score for AVIR is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
Atea Pharmaceuticals, Inc. Stock Info
Market Cap:
285.2M
Price in USD:
3.65
Share Volume:
375.3K
Atea Pharmaceuticals, Inc. 52-Week Range
52-Week High:
4.02
52-Week Low:
2.46
Sell
46
Atea Pharmaceuticals, Inc. (AVIR)
is a Sell
Atea Pharmaceuticals, Inc. Share Price Forecast
-
What is the Atea Pharmaceuticals, Inc. stock price today?The Atea Pharmaceuticals, Inc. stock price is 3.65 USD today.
-
Will AVIR stock go up or go down?Atea Pharmaceuticals, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is Atea Pharmaceuticals, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Atea Pharmaceuticals, Inc. is overvalued.
Is Atea Pharmaceuticals, Inc. Stock a Buy?
-
Atea Pharmaceuticals, Inc. share price is 3.65 while AVIR 8-day exponential moving average is 3.35, which is a Buy signal.
-
The stock price of AVIR is 3.65 while Atea Pharmaceuticals, Inc. 20-day EMA is 3.23, which makes it a Buy.
-
Atea Pharmaceuticals, Inc. 50-day exponential moving average is 3.19 while AVIR share price is 3.65, making it a Buy technically.
-
AVIR stock price is 3.65 and Atea Pharmaceuticals, Inc. 200-day simple moving average is 3.22, creating a Buy signal.
Fundamental Analysis of Atea Pharmaceuticals, Inc.
Is Atea Pharmaceuticals, Inc. a good investment?
-
Analysts estimate an earnings increase this quarter of $0.05 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.08 per share, and a decrease next year of $0.02 per share.
Technical Analysis of Atea Pharmaceuticals, Inc.
Should I short Atea Pharmaceuticals, Inc. stock?
-
AVIR Moving Average Covergence Divergence (MACD) indicator is 0.08, suggesting Atea Pharmaceuticals, Inc. is a Buy
-
Atea Pharmaceuticals, Inc. Relative Strength Index (RSI) is 73.88, which suggest Atea Pharmaceuticals, Inc. is overbought
-
The Bollinger Bands (25) for Atea Pharmaceuticals, Inc. is (2.99 - 3.31), which suggest Atea Pharmaceuticals, Inc. is a Buy
-
The Bollinger Bands (100) for Atea Pharmaceuticals, Inc. is (3 - 3.42), which suggest Atea Pharmaceuticals, Inc. is a Buy
* Atea Pharmaceuticals, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.